Editor, Ophthalmology Times
MediPrint Ophthalmics reveals positive results from phase 2b study of LL-BMT1 contact lens
November 12th 2024The weekly drug-eluting contact lens was created by the company’s proprietary 3D printing technology and met all primary endpoints with no serious adverse events reported in either cohort.
Read More
AAO 2024: Alfredo Sadun on the aging ophthalmologist
November 2nd 2024Alfredo Sadun, MD, PhD, is the chief of Ophthalmology at the Doheny Eye Institute of UCLA. At this year's AAO meeting held in Chicago, Illinois, he stopped by the Eye Care Network booth to share insights from the symposium "Professional Longevity 2.0: Assessing the Ophthalmologist," which he presented during.
Read More
AAO 2024: Gildeuretinol and Stargardt disease: The TEASE program
October 20th 2024Christine Kay, MD sat down to discuss her presentation on gildeuretinol and its slowing of progression of Stargardt disease, studied in the TEASE program at this year's American Academy of Ophthalmology meeting held in Chicago, Illinois.
Read More
AAO 2024: Teleretinal screening for diabetic eye disease
October 20th 2024Christina Y Weng, MD, MBA sat down to discuss the Retina Ophthalmic Technology Assessment Symposium and her journal on teleretinal screening for diabetic eye disease at this year's American Academy of Ophthalmology meeting held in Chicago, Illinois.
Read More